Literature DB >> 10495390

Linear porokeratosis superimposed on disseminated superficial actinic porokeratosis: report of two cases exemplifying the concept of type 2 segmental manifestation of autosomal dominant skin disorders.

P Freyschmidt-Paul1, R Hoffmann, A König, R Happle.   

Abstract

A concept of dichotomous types of segmental involvement of autosomal dominant skin disorders has recently been proposed. Among the different types of porokeratosis, disseminated superficial actinic porokeratosis is known to be an autosomal dominant skin disorder, and linear porokeratosis represents the segmental form of the disease. We intended to exemplify the type 2 segmental manifestation within this concept. Clinical and histopathologic aspects of porokeratotic lesions of 2 patients were investigated. The family history was studied in both cases. Linear porokeratosis superimposed on disseminated superficial actinic porokeratosis was observed in both patients. These 2 cases of linear porokeratosis associated with disseminated superficial actinic porokeratosis can be taken as further examples of a type 2 segmental involvement occurring in an autosomal dominant skin disorder.

Entities:  

Mesh:

Year:  1999        PMID: 10495390

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

1.  A novel locus for disseminated superficial actinic porokeratosis maps to chromosome 16q24.1-24.3.

Authors:  Jing Luan; Zhenmin Niu; Jing Zhang; Meredith E Crosby; Zhenghua Zhang; Xun Chu; Zhimin Wang; Wei Huang; Leihong Xiang; Zhizhong Zheng
Journal:  Hum Genet       Date:  2010-12-14       Impact factor: 4.132

2.  Mixed porokeratosis with a novel mevalonate kinase gene mutation: A case report.

Authors:  Hong-Jun Xu; Guang-Dong Wen
Journal:  World J Clin Cases       Date:  2022-05-16       Impact factor: 1.534

3.  Disseminated superficial and warty type of porokeratosis: a rare coexistence.

Authors:  Kusumika Kanak; A K Jaiswal; Pallavi Reddy
Journal:  Indian J Dermatol       Date:  2011 Sep-Oct       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.